Adverse Events of Peripherally Administered Norepinephrine During Surgery: A Prospective Multicenter Study

Anesth Analg. 2024 Jun 1;138(6):1242-1248. doi: 10.1213/ANE.0000000000006806. Epub 2024 Jan 5.

Abstract

Background: Perioperative treatment of hypotension by intravenous administration of norepinephrine in a peripheral vein can lead to adverse events, for example, tissue necrosis. However, the incidence and severity of adverse events during perioperative administration are unknown.

Methods: This was a prospective observational study conducted at 3 Swedish hospitals from 2019 to 2022. A total of 1004 patients undergoing surgery, who met the criteria for perioperative peripheral norepinephrine administration, were included. The infusion site was inspected regularly. If swelling or paleness of skin was detected, the infusion site was changed to a different peripheral line. Systolic blood pressure and pulse frequency were monitored during the infusion time and defined as adverse events at >220 mm Hg and <40 beats•min -1 . In case of adverse events, patients were observed for up to 48 hours. The primary outcome was prevalence of extravasation, defined as swelling around the infusion site. Secondary outcomes were all types of adverse events and associations between predefined clinical variables and risk of adverse events.

Results: We observed 2.3% (95% confidence interval [CI], 1.4%-3.2%) extravasation of infusion and 0.9% (95% CI, 0.4%-1.7%) bradycardia. No cases of tissue necrosis or severe hypertension were detected. All adverse events had dissipated spontaneously within 48 hours. Proximal catheter placement was associated with more adverse events.

Conclusions: Extravasation of peripherally administrated norepinephrine in the perioperative period occurred at similar rates as in previous studies in critically ill patients. In our setting, where we regularly inspected the infusion site and shifted site in case of swelling or paleness of skin, we observed no case of severe adverse events. Given that severe adverse events were absent, the potential benefit of this preventive approach requires confirmation in a larger population.

Publication types

  • Multicenter Study
  • Observational Study

MeSH terms

  • Adult
  • Aged
  • Catheterization, Peripheral / adverse effects
  • Female
  • Humans
  • Hypotension / chemically induced
  • Hypotension / diagnosis
  • Hypotension / epidemiology
  • Infusions, Intravenous
  • Male
  • Middle Aged
  • Norepinephrine* / administration & dosage
  • Norepinephrine* / adverse effects
  • Prospective Studies
  • Risk Factors
  • Sweden / epidemiology
  • Vasoconstrictor Agents* / administration & dosage
  • Vasoconstrictor Agents* / adverse effects